Page last updated: 2024-10-25

clonazepam and Chronic Illness

clonazepam has been researched along with Chronic Illness in 35 studies

Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.

Research Excerpts

ExcerptRelevanceReference
"A randomized, double-blind controlled trial is reported comparing phenobarbital and clonazepam for the purpose of sedative-hypnotic taper in inpatients with chronic, nonmalignant pain."9.07Phenobarbital versus clonazepam for sedative-hypnotic taper in chronic pain patients. A pilot study. ( Lynn, P; Roy-Byrne, P; Sullivan, M; Toshima, M, 1993)
"The results suggest that clonazepam may be helpful in burning mouth syndrome, inasmuch as 70% of patients (groups 1 and 2) experienced pain reduction with effects at low doses."7.70An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome. ( Epstein, J; Grushka, M; Mott, A, 1998)
"Clonazepam was used in 22 instances of status epilepticus by intravenous route with particularly good results."7.65[Electroclinical correlations during anticonvulsive therapy of status epilepticus and chronic focal epilepsies using clonazepam]. ( Bücking, PH, 1977)
"Clonazepam was added to the neuroleptic regimen of 3 treatment-resistant schizophrenic patients with schizoaffective features."6.67Adjunctive clonazepam in the treatment of chronic schizophrenia. ( Alvarez, WA; Freinhar, JP; Herrera, JM; Lawson, WB; Sramek, JJ, 1991)
"A randomized, double-blind controlled trial is reported comparing phenobarbital and clonazepam for the purpose of sedative-hypnotic taper in inpatients with chronic, nonmalignant pain."5.07Phenobarbital versus clonazepam for sedative-hypnotic taper in chronic pain patients. A pilot study. ( Lynn, P; Roy-Byrne, P; Sullivan, M; Toshima, M, 1993)
"The results suggest that clonazepam may be helpful in burning mouth syndrome, inasmuch as 70% of patients (groups 1 and 2) experienced pain reduction with effects at low doses."3.70An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome. ( Epstein, J; Grushka, M; Mott, A, 1998)
"Clonazepam was used in 22 instances of status epilepticus by intravenous route with particularly good results."3.65[Electroclinical correlations during anticonvulsive therapy of status epilepticus and chronic focal epilepsies using clonazepam]. ( Bücking, PH, 1977)
"Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep resulted in sustained efficacy in most cases, with low risk of dosage tolerance, adverse effects, or abuse."2.68Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. ( Mahowald, MW; Schenck, CH, 1996)
"Clonazepam was added to the neuroleptic regimen of 3 treatment-resistant schizophrenic patients with schizoaffective features."2.67Adjunctive clonazepam in the treatment of chronic schizophrenia. ( Alvarez, WA; Freinhar, JP; Herrera, JM; Lawson, WB; Sramek, JJ, 1991)
"Clonazepam was selected for its long duration and its cholinergic/GABA-ergic/serotonergic, anxiolytic, muscle relaxant, and sedative properties."2.67Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double-blind pilot study. ( Cohen, J; Cueva, L; Harkins, S; Kramer, T; Linford, J, 1991)
"Zolpidem is an imidazopyridine nonbenzodiazepine hypnotic drug with a high affinity to the α1 subunit of the gamma amino butyric acid A receptor It is the first pharmacological option in the short-term management of sleep-onset insomnia."1.48Severe Chronic Abuse of Zolpidem in Refractory Insomnia. ( Bianco, G; Castelnovo, A; Chiaro, G; Maffei, P; Manconi, M, 2018)
"Burning Mouth Syndrome (BMS) is a chronic pain condition characterized by persistent intraoral burning without related objective findings and unknown etiology that affects elderly females mostly."1.46Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbiities, treatment and outcome. ( Deligianni, CI; Ljubisavljevic, S; Mitsikostas, DD, 2017)
"In total, 181 chronic insomnia patients were consecutively recruited."1.46Low serum 25-hydroxyvitamin D concentrations in chronic insomnia patients and the association with poor treatment outcome at 2months. ( Chen, H; He, J; Liu, Y; Luan, X; Qiu, H; Shen, H; Tu, X; Zhao, K; Zhu, Z, 2017)
"Clonazepam (CNZ) is a drug used for insomnia treatment."1.42Executive dysfunction in patients with chronic primary insomnia treated with clonazepam. ( Contreras-González, N; Haro, R; Jiménez-Correa, U; Poblano, A; Téllez-Alanís, B, 2015)
"Clonazepam has been shown to be an effective supplementary treatment for depression."1.34Possible predictors of response to clonazepam augmentation therapy in patients with protracted depression. ( Arita, S; Morishita, S, 2007)
"Clonazepam is a potent, long-acting benzodiazepine approved for use in myoclonic and petit mal seizures."1.28Mania associated with clonazepam. ( Dorevitch, A, 1991)

Research

Studies (35)

TimeframeStudies, this research(%)All Research%
pre-19908 (22.86)18.7374
1990's16 (45.71)18.2507
2000's6 (17.14)29.6817
2010's5 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mitsikostas, DD1
Ljubisavljevic, S1
Deligianni, CI1
Zhao, K1
Luan, X1
Liu, Y1
Tu, X1
Chen, H1
Shen, H1
Qiu, H1
Zhu, Z1
He, J1
Chiaro, G1
Castelnovo, A1
Bianco, G1
Maffei, P1
Manconi, M1
Contreras-González, N1
Téllez-Alanís, B1
Haro, R1
Jiménez-Correa, U1
Poblano, A1
Williams, BS1
Wong, D1
Amin, S1
Danhauer, SC1
Miller, CS1
Rhodus, NL1
Carlson, CR1
Goforth, HW1
Rao, M1
Sucholeiki, R1
Morishita, S1
Arita, S1
Matsuo, M1
Takahashi, Y1
Taniguchi, K1
Sasaki, K1
Hamasaki, Y1
Swerdlow, M1
Cundill, JG1
Banfi, S1
Fonio, W1
Allievi, E1
Raimondo, S1
Baraczka, K1
Molnár, G1
Sodeyama, N1
Orimo, S1
Okiyama, R1
Arai, M1
Tamaki, M1
Sullivan, M1
Toshima, M1
Lynn, P1
Roy-Byrne, P1
Schenck, CH3
Mahowald, MW3
Gibbs, JW1
Morton, LD1
Amaker, B1
Ward, JD1
Holloway, KL1
Coulter, DA1
Perney, P1
Butterworth, RF1
Mousseau, DD1
Lavoie, J1
Fabbro-Peray, P1
Blanc, F1
Layrargues, GP1
Grushka, M1
Epstein, J1
Mott, A1
Bundlie, SR1
Ettinger, MG1
Penin, H1
Shakir, RA1
Nanda, RN1
Lambie, DG1
Johnson, RH1
Bücking, PH1
Palacios, E1
Court, J1
Kase, JC1
Horiguchi, J1
Nishimatsu, O1
Saltz, BL1
Hampf, G1
Kuoppasalmi, K1
Henriksson, M1
Achté, K1
Herrera, JM1
Alvarez, WA1
Freinhar, JP1
Lawson, WB1
Sramek, JJ1
Harkins, S1
Linford, J1
Cohen, J1
Kramer, T1
Cueva, L1
Klein, DS1
Schmidt, RE1
Dorevitch, A1
Bakheit, AM1
Behan, PO1
Pollack, MH1
Otto, MW1
Rosenbaum, JF1
Sachs, GS1
O'Neil, C1
Asher, R1
Meltzer-Brody, S1
Sher, PK1
Arai, K1
Tokumaru, Y1
Yagishita, T1
Hirayama, K1
Iwasaki, I1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Prospective Study on the Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine(TCM) and Western Medicine Based on TCM Syndrome Differentiation[NCT04189367]Phase 380 participants (Anticipated)Interventional2020-06-20Not yet recruiting
Redictive Risk Factors of Conversion Into Idiopathic RBD. Italian Study [FAttori di Rischio PREdittivi di Conversione Nell'RBD Idiopatico. STudio ItalianO[NCT05262543]300 participants (Anticipated)Observational2020-05-25Recruiting
The Role of Orexin in Human Panic Disorder[NCT02593682]Phase 43 participants (Actual)Interventional2016-05-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for clonazepam and Chronic Illness

ArticleYear
REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP.
    Sleep, 2002, Mar-15, Volume: 25, Issue:2

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Chronic Disease; Clonazepam; Diagnosis, Differential; Elec

2002
[Long-term anticonvulsant therapy (author's transl)].
    Der Nervenarzt, 1978, Volume: 49, Issue:9

    Topics: Anticonvulsants; Carbamazepine; Chronic Disease; Clonazepam; Epilepsy; Ethosuximide; Humans; Long-Te

1978

Trials

6 trials available for clonazepam and Chronic Illness

ArticleYear
Impact of criteria-based diagnosis of burning mouth syndrome on treatment outcome.
    Journal of orofacial pain, 2002,Fall, Volume: 16, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Anxiety Agents; Anticonvulsants; Burning Mouth Syndrome; Carbam

2002
Phenobarbital versus clonazepam for sedative-hypnotic taper in chronic pain patients. A pilot study.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1993, Volume: 5, Issue:2

    Topics: Adult; Anxiety Disorders; Chronic Disease; Clonazepam; Double-Blind Method; Female; Hospitalization;

1993
Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults.
    The American journal of medicine, 1996, Volume: 100, Issue:3

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Chronic Disease; Clonazepam; Drug Administration Schedule; F

1996
Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study.
    The Japanese journal of psychiatry and neurology, 1992, Volume: 46, Issue:3

    Topics: Akathisia, Drug-Induced; Antiparkinson Agents; Antipsychotic Agents; Chronic Disease; Clonazepam; Do

1992
Adjunctive clonazepam in the treatment of chronic schizophrenia.
    International journal of psychosomatics : official publication of the International Psychosomatics Institute, 1991, Volume: 38, Issue:1-4

    Topics: Adult; Antipsychotic Agents; Chronic Disease; Clonazepam; Drug Therapy, Combination; Female; Humans;

1991
Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double-blind pilot study.
    Journal of craniomandibular disorders : facial & oral pain, 1991,Summer, Volume: 5, Issue:3

    Topics: Adolescent; Adult; Chronic Disease; Clonazepam; Double-Blind Method; Female; Humans; Male; Middle Ag

1991

Other Studies

27 other studies available for clonazepam and Chronic Illness

ArticleYear
Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbiities, treatment and outcome.
    The journal of headache and pain, 2017, Volume: 18, Issue:1

    Topics: Aged; Anticonvulsants; Anxiety; Burning Mouth Syndrome; Chronic Disease; Chronic Pain; Clonazepam; C

2017
Low serum 25-hydroxyvitamin D concentrations in chronic insomnia patients and the association with poor treatment outcome at 2months.
    Clinica chimica acta; international journal of clinical chemistry, 2017, Volume: 475

    Topics: Adult; Antidepressive Agents; Azabicyclo Compounds; Biomarkers; Case-Control Studies; Chronic Diseas

2017
Severe Chronic Abuse of Zolpidem in Refractory Insomnia.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018, 07-15, Volume: 14, Issue:7

    Topics: Aged; Anticonvulsants; Chronic Disease; Clonazepam; Female; Hospitalization; Humans; Levetiracetam;

2018
Executive dysfunction in patients with chronic primary insomnia treated with clonazepam.
    Neurological research, 2015, Volume: 37, Issue:12

    Topics: Adult; Anticonvulsants; Attention; Chronic Disease; Clonazepam; Cognition Disorders; Executive Funct

2015
Case scenario: self-extraction of intrathecal pump medication with a concomitant intrathecal granulomatous mass.
    Anesthesiology, 2011, Volume: 114, Issue:2

    Topics: Acetaminophen; Administration, Cutaneous; Adult; Analgesics; Analgesics, Non-Narcotic; Analgesics, O

2011
Chronic interictal psychosis responsive to aripiprazole.
    Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:5

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Chronic Disease; Clonazepam; Delusions;

2004
Possible predictors of response to clonazepam augmentation therapy in patients with protracted depression.
    Human psychopharmacology, 2007, Volume: 22, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Antidepressive Agents; Bipolar Disorder; Chronic Di

2007
Chronic myoclonia of subcortical origin with antiglutamate receptor antibodies.
    Journal of child neurology, 2007, Volume: 22, Issue:12

    Topics: Antibody Specificity; Anticonvulsants; Autoantibodies; Child; Chronic Disease; Clonazepam; Electroen

2007
Anticonvulsant drugs used in the treatment of lancinating pain. A comparison.
    Anaesthesia, 1981, Volume: 36, Issue:12

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Chronic Disease; Clonazepam; Female; Humans

1981
Experimental chronic epilepsy in rats: a screening method for antiepileptic drugs.
    Pharmacological research communications, 1983, Volume: 15, Issue:5

    Topics: Animals; Anticonvulsants; Chlorides; Chronic Disease; Clonazepam; Diazepam; Disease Models, Animal;

1983
Possible drug interaction in chronic treatment of epileptic patients: serum level studies.
    Monographs in neural sciences, 1980, Volume: 5

    Topics: Adolescent; Adult; Anticonvulsants; Brain Damage, Chronic; Chronic Disease; Clonazepam; Drug Interac

1980
[A case of chronic thinner intoxication developing hyperkinésie volitionnelle three years after stopping thinner abuse].
    Rinsho shinkeigaku = Clinical neurology, 1993, Volume: 33, Issue:2

    Topics: Adult; Brain; Chronic Disease; Clonazepam; Humans; Hyperkinesis; Male; Substance-Related Disorders;

1993
Physiological analysis of Rasmussen's encephalitis: patch clamp recordings of altered inhibitory neurotransmitter function in resected frontal cortical tissue.
    Epilepsy research, 1998, Volume: 31, Issue:1

    Topics: Cell Size; Cells, Cultured; Cerebral Cortex; Child; Chronic Disease; Clonazepam; Dose-Response Relat

1998
Plasma and CSF benzodiazepine receptor ligand concentrations in cirrhotic patients with hepatic encephalopathy: relationship to severity of encephalopathy and to pharmaceutical benzodiazepine intake.
    Metabolic brain disease, 1998, Volume: 13, Issue:3

    Topics: Animals; Benzodiazepines; Binding, Competitive; Cell Fractionation; Cerebellum; Chronic Disease; Clo

1998
An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 1998, Volume: 86, Issue:5

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Burning Mouth Syndrome; Chronic Disease; Clonazepam;

1998
Chronic behavioral disorders of human REM sleep: a new category of parasomnia. 1986 [classical article].
    Sleep, 2002, Mar-15, Volume: 25, Issue:2

    Topics: Aged; Anticonvulsants; Antidepressive Agents, Tricyclic; Brain; Chronic Disease; Clonazepam; Desipra

2002
Comparative trial of valproate sodium and clonazepam in chronic epilepsy.
    Archives of neurology, 1979, Volume: 36, Issue:5

    Topics: Adult; Ataxia; Benzodiazepinones; Chronic Disease; Clonazepam; Drug Therapy, Combination; Epilepsy;

1979
[Electroclinical correlations during anticonvulsive therapy of status epilepticus and chronic focal epilepsies using clonazepam].
    Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie, 1977, Volume: 121, Issue:2

    Topics: Adolescent; Adult; Benzodiazepinones; Brain; Chronic Disease; Clonazepam; Electroencephalography; Ep

1977
[Epilepsy refractary to usual treatment: the effect of clonazepam (author's transl)].
    Revista medica de Chile, 1976, Volume: 104, Issue:9

    Topics: Adolescent; Benzodiazepinones; Child; Child, Preschool; Chronic Disease; Clonazepam; Drug Evaluation

1976
Tardive dyskinesia in the elderly patient.
    Hospital practice (Office ed.), 1992, Apr-15, Volume: 27, Issue:4

    Topics: Aged; Chlorpromazine; Chronic Disease; Clonazepam; Clozapine; Depressive Disorder; Desipramine; Diph

1992
Chronic facial pain together with severe depression is responsive to electroconvulsive therapy. A case report.
    Acta odontologica Scandinavica, 1992, Volume: 50, Issue:3

    Topics: Amitriptyline; Chronic Disease; Clonazepam; Depressive Disorder; Electroconvulsive Therapy; Facial P

1992
Chronic headache resulting from postoperative supraorbital neuralgia.
    Anesthesia and analgesia, 1991, Volume: 73, Issue:4

    Topics: Bupivacaine; Chronic Disease; Clonazepam; Female; Headache; Humans; Middle Aged; Nerve Block; Neural

1991
Mania associated with clonazepam.
    DICP : the annals of pharmacotherapy, 1991, Volume: 25, Issue:9

    Topics: Acute Disease; Adult; Bipolar Disorder; Chronic Disease; Clonazepam; Humans; Male; Schizophrenia

1991
Palatal myoclonus successfully treated with clonazepam.
    Journal of neurology, neurosurgery, and psychiatry, 1990, Volume: 53, Issue:9

    Topics: Aged; Chronic Disease; Clonazepam; Female; Humans; Myoclonus; Neurologic Examination; Palatal Muscle

1990
Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl A

    Topics: Alprazolam; Anxiety Disorders; Child, Preschool; Chronic Disease; Clonazepam; Cognitive Behavioral T

1990
The effects of acidosis on chronically hypoxic neurons in culture.
    Experimental neurology, 1990, Volume: 107, Issue:3

    Topics: Acidosis; Animals; Benzodiazepines; Benzodiazepinones; Binding, Competitive; Cells, Cultured; Chroni

1990
[Chronic toluene intoxication and hyperkinésie volitionnelle].
    No to shinkei = Brain and nerve, 1986, Volume: 38, Issue:12

    Topics: Adult; Brain; Chronic Disease; Clonazepam; Electromyography; Gliosis; Humans; Hyperkinesis; Male; To

1986